Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

The success and challenges of developing different tuberculosis (TB) vaccine types.

Second Drug OK’d for Ultra-Rare Neurodegenerative Disease

The FDA gave the green light to levacetylleucine (Aqneursa) as a stand-alone treatment for Niemann-Pick disease type C (NPC), just days after approving the first

September 26, 2024

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million – Biotech Investments

Heidelberg Pharma AG / Key word(s): Financing Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million 04-March-2024 / 11:02

March 5, 2024

Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. If anything will

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.